Pasurta

Pasurta Overdosage

erenumab

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Overdosage
There is no experience with overdose in clinical trials with Pasurta. Doses up to 280 mg SC have been administered in clinical trials with no evidence of dose limiting toxicity.
In the event of an overdose, the patient should be treated symptomatically and supportive measures instituted as required.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in